SXTP
What one share of 60 Degrees Pharmaceuticals holds
Pharmaceutical Preparations
Australia previously solely owned a Singaporean subsidiary company, 60P Singapore Pte. Ltd., which dissolved at our election in the second quarter of 2022.
60 Degrees Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.70 |
|---|---|
| Profit | −$5.41 |
| Capex (buildings and equipment) | $0.08 |
| Free cash flow | −$5.58 |
| Cash and investments | $0.38 |
| Debt | $0.06 |
| Book value | $0.98 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $1.89 | −$52.22 | — | −$8.53 | — | −$199.15 |
| 2023 | $15.30 | −$236.73 | $3.48 | −$277.50 | — | $201.15 |
| 2024 | $5.35 | −$74.17 | $0.91 | −$50.60 | — | $28.47 |
| 2025 | $1.50 | −$11.73 | $0.21 | −$10.43 | — | $2.98 |